Prime Medicine PRME
NASDAQ PRME
$4.03 -0.27 (-6.26%)
As of: Nov 12, 2026 · 9:31 AM EST

Prime Medicine (PRME) Return on Capital Employed [ROCE] (2022 - 2026)

Updated

Prime Medicine (PRME) posted Return on Capital Employed [ROCE] of -81.82% for Q2 2026, down 6.03 percentage points from -75.78% a year earlier and down 8.67 percentage points from the prior quarter.

Analysis

Prime Medicine (PRME) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends

For FY2025, Prime Medicine's Return on Capital Employed [ROCE] came in at -73.71%, up 23.76 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a three-year change of -35.42 percentage points (FY2022 to FY2025).
  • In prior years, Prime Medicine's Return on Capital Employed [ROCE] was -97.47% in FY2024 (-4.66 pp), -92.81% in FY2023 (-54.52 pp) and -38.29% in FY2022.
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in six of the last eight quarters, with an average year-over-year change of +12.22 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2024, with a gain of 54.89 percentage points; the weakest was Q4 2023, with a drop of 83.30 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -73.15% (Q1 2026), -63.83% (Q4 2025) and -68.68% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Prime Medicine 704.88 Mn 469.45 Mn - -83.80%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -83.80%
Mar 31, 2026 -74.49%
Sep 30, 2025 -68.68%
Jun 30, 2025 -75.78%
Mar 31, 2025 -74.14%
Dec 31, 2024 -73.04%
Sep 30, 2024 -87.58%
Jun 30, 2024 -84.41%
Mar 31, 2024 -93.39%
Dec 31, 2023 -127.94%
Sep 30, 2023 -79.51%
Jun 30, 2023 -57.60%
Mar 31, 2023 -43.42%
Dec 31, 2022 -44.64%
API Access

Prime Medicine Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PRME&period=max&api_key=YOUR_API_KEY